Beta-cell function in juvenile diabetes and obesity
NOVEL PREP1-DEPENDENT TRANSCRIPTIONAL NETWORKS IN THE CONTROL OF INSULIN SENSITIVITY
Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population
DIAbetes type 1 PRediction, Early Pathogenesis and Prevention
Identification of epigenetic markers underlying increased risk of T2D in South Asians
Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems.
Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention
Adipokines as Drug Targets to Combat Adverse Effects of Excess Adipose Tissue
Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes
|G. BECK-SICKINGER Annette
Gastro-intestinal Peptides in Obesity
Sensory and Biomechanical Markers in Diabetic Neuropathy of the Gut. Basic Investigations and New Approaches for Treatment
Genetic and environmental factors of insulin resistance syndrome and its long-term complications in immigrant Mediterranean populations
Use of innovative strategies for beta-cell imaging in diabetes mellitus
Collaborative European effort to Develop Diabetes Diagnostics
Recruitment and activation of brown adipocytes as preventive and curative therapy for type 2 diabetes
Genomic and lifestyle predictors of foetal outcome relevant to diabetes and obesity and their relevance to prevention strategies in South Asian peoples.
Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes
Pathogenesis of Type 1 Diabetes - Testing the Hygiene Hypothesis
Novel immunotherapies for type 1 diabetes.
Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression.
Repair of Diabetic Damage by Stromal Cell Administration
|P. A. HALBAN
Road Map for Diabetes Research in Europe
Single-Port Insulin Infusion for Improved Diabetes Management
Search for new therapeutic agents against complicated obesity by reprofiling existing drugs
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria
A bioartificial pancreas to treat type 1 diabetes: optimization of cell survival and function in preclinical and clinical phases
|SIMO CANONGE Rafael
European Consortium for the Early Treatment of Diabetic Retinopathy
Type 2 diabetes and obesity among sub-Saharan African native and migrant populations: dissection of environment and endogenous predisposition
Targeting OBesity-driven Inflammation
Developing predictors of the health benefits of exercise for individuals
Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe
|DE VRIES Hans
A Portable bihormonal Closed Loop for Diabetes
|Dr YEO Giles
European Obesity Consortium studying the Hypothalamus and its Interaction with Peripheral organs.
Global initiative on gene-environment interaction on diabetes/obesity risk